Neuren also got a mention in the latest article on AFR by
Morgan senior analyst Scott Power as a potential take over target in 2020
Mr Power's other picks for takeover targets in the sector include recent investor favourite Opthea radiation treatment firm Telix Pharmaceuticals, Volpara and Neuren Pharmaceuticals, which is developing therapies for neurodevelopmental disorders.
Closest to market!!!, page-5
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.26 |
Change
0.080(0.61%) |
Mkt cap ! $1.698B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.41 | $13.12 | $2.347M | 177.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605 | $13.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.27 | 832 | 12 |
View Market Depth
| Last trade - 14.02pm 10/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |